Cargando…

Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice: Involvement of reduced S100A11 expression

Dimethylarginine dimethylaminohydrolase 1 (DDAH1) is an important regulator of plasma asymmetric dimethylarginine (ADMA) levels, which are associated with insulin resistance in patients with nonalcoholic fatty liver disease (NAFLD). To elucidate the role of hepatic DDAH1 in the pathogenesis of NAFLD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Xiyue, Luo, Kai, Yuan, Juntao, Gao, Junling, Cui, Bingqing, Yu, Zhuoran, Lu, Zhongbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465955/ https://www.ncbi.nlm.nih.gov/pubmed/37655336 http://dx.doi.org/10.1016/j.apsb.2023.05.020

Ejemplares similares

Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation
por: Yuan, Juntao, et al.
Publicado: (2021)

DDAH1 Protects against Acetaminophen-Induced Liver Hepatoxicity in Mice
por: Shen, Xiyue, et al.
Publicado: (2022)

Genetic and Pharmacological Inhibition of GCN2 Ameliorates Hyperglycemia and Insulin Resistance in Type 2 Diabetic Mice
por: Yuan, Juntao, et al.
Publicado: (2022)

DDAH1 Protects against Cardiotoxin-Induced Muscle Injury and Regeneration
por: Feng, Fei, et al.
Publicado: (2023)

Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice
por: Krumm, Christopher S., et al.
Publicado: (2021)

Inhibition of GCN2 Alleviates Cardiomyopathy in Type 2 Diabetic Mice via Attenuating Lipotoxicity and Oxidative Stress
por: Yuan, Juntao, et al.
Publicado: (2022)

Molecular mechanisms involved in hepatic steatosis and insulin resistance
por: Matsuzaka, Takashi, et al.
Publicado: (2011)

Hepatic glucose utilization in hepatic steatosis and obesity
por: Keramida, Georgia, et al.
Publicado: (2016)

Metformin protects against PM(2.5)-induced lung injury and cardiac dysfunction independent of AMP-activated protein kinase α2
por: Gao, Junling, et al.
Publicado: (2019)

Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
por: Kern, Matthias, et al.
Publicado: (2012)

Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance
por: Qiao, Lu, et al.
Publicado: (2022)

Insulin resistance, steatosis and hepatitis C virus
por: Mangia, Alessandra, et al.
Publicado: (2013)

Hepatitis C Virus, Insulin Resistance, and Steatosis
por: Kralj, Dominik, et al.
Publicado: (2016)

Vanadium(IV)-Chlorodipicolinate Protects against Hepatic Steatosis by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammation
por: Wang, Yuanli, et al.
Publicado: (2022)

Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers
por: Lai, Li, et al.
Publicado: (2016)

Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism
por: Qiao, Xin, et al.
Publicado: (2019)

Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice
por: Chang, Ting-Chen, et al.
Publicado: (2019)

Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
por: Radlinger, Bernhard, et al.
Publicado: (2022)

Sesamol Alleviates Obesity-Related Hepatic Steatosis via Activating Hepatic PKA Pathway
por: Xu, Hai-Yan, et al.
Publicado: (2020)

Changes in ADMA/DDAH Pathway after Hepatic Ischemia/Reperfusion Injury in Rats: The Role of Bile
por: Ferrigno, Andrea, et al.
Publicado: (2014)

Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
por: Deveaux, Vanessa, et al.
Publicado: (2009)

Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjects
por: Isaksen, Victoria T., et al.
Publicado: (2016)

Targeting peroxisomal fatty acid oxidation improves hepatic steatosis and insulin resistance in obese mice
por: Yao, Haoya, et al.
Publicado: (2022)

Insulin Resistance, but Not Obstructive Sleep Apnea Is Associated with Hepatic Steatosis in Chinese Patients with Severe Obesity
por: Zhu, Chonggui, et al.
Publicado: (2023)

Assessment of DDAH1 and DDAH2 Contributions to Psychiatric Disorders via In Silico Methods
por: Kozlova, Alena A., et al.
Publicado: (2022)

Metabolic Consequences of Hepatic Steatosis in Overweight and Obese Adolescents
por: Wicklow, Brandy A., et al.
Publicado: (2012)

Nutritional Approaches in Children with Overweight or Obesity and Hepatic Steatosis
por: Spiezia, Chiara, et al.
Publicado: (2023)

Monkfish Peptides Mitigate High Fat Diet-Induced Hepatic Steatosis in Mice
por: Ye, Jiena, et al.
Publicado: (2022)

Dynapenia, Muscle Quality, and Hepatic Steatosis in Patients with Obesity and Sarcopenic Obesity
por: Frigerio, Francesco, et al.
Publicado: (2023)

Loss of Regulator of G Protein Signaling 5 Exacerbates Obesity, Hepatic Steatosis, Inflammation and Insulin Resistance
por: Deng, Wei, et al.
Publicado: (2012)

Loss of TDAG51 Results in Mature-Onset Obesity, Hepatic Steatosis, and Insulin Resistance by Regulating Lipogenesis
por: Basseri, Sana, et al.
Publicado: (2013)

Adipose-Specific Deficiency of Fumarate Hydratase in Mice Protects Against Obesity, Hepatic Steatosis, and Insulin Resistance
por: Yang, Hao, et al.
Publicado: (2016)

Dietary Eriodictyol Alleviates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obese Mice
por: Kwon, Eun-Young, et al.
Publicado: (2019)

Functional beverages improve insulin resistance and hepatic steatosis modulating lysophospholipids in diet‐induced obese rats
por: Rubio‐Rodríguez, Julio C., et al.
Publicado: (2021)

Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease
por: Semmler, Georg, et al.
Publicado: (2023)

Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016)

Cancer and hepatic steatosis
por: Paternostro, R., et al.
Publicado: (2021)

Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver
por: Zhang, Yuehui, et al.
Publicado: (2018)

Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance
por: Lee, Hui-Young, et al.
Publicado: (2011)

Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans
por: ter Horst, Kasper W., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iu2aa7toi7e1013m2e9bomout2